首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1733685

冠狀動脈繞道手術設備市場（依產品類型、最終用戶和地區）2026 年至 2032 年

Coronary Artery Bypass Graft Devices Market By Product Type (On-Pump CABG Devices, Off-Pump CABG Devices, Minimally Invasive CABG Devices), By End-User (Hospitals, Cardiac Surgery Centers, Ambulatory Surgical Centers), Region For 2026-2032

出版日期: 2025年04月29日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

冠狀動脈繞道手術裝置市場評估 - 2026-2032

人口老化正在推動冠狀動脈繞道手術手術（CABG）設備的成長。隨著年齡的成長，我們更容易罹患心臟病，包括冠狀動脈疾病（CAD）。這些人口結構的變化將導致 CAD 盛行率上升，從而推動對旨在有效管理和治療這些疾病的 CABG 手術和設備的需求。因此，老年人口的增加將倍增市場規模的成長，到2024年將超過120億美元，到2032年將達到202.7億美元的估值。

人們對 CAD 風險因素和早期檢測重要性的認知不斷提高，導致了更積極的篩檢和診斷。隨著社會對心臟病認知的提高，人們越來越重視早期識別風險因素並採取預防措施。這種認知的提高意味著對診斷和治療方案（包括 CABG 設備）的需求增加。隨著醫療保健系統和患者尋求先進的解決方案來解決和管理冠狀動脈疾病，老齡化人口的增加加上積極主動的健康實踐正在刺激 CABG 設備市場的成長。因此，對 CAD 認知的不斷提高將使市場在 2026 年至 2032 年期間的複合年成長率達到 7%。

冠狀動脈繞道手術裝置市場定義/概述

冠狀動脈繞道手術手術 (CABG) 是一種主要的醫療程序，旨在治療冠狀動脈疾病 (CAD)，其特徵是冠狀動脈狹窄或阻塞。這項外科手術旨在透過創造一條替代的血液循環途徑來改善心肌的血流。在手術過程中，外科醫生使用移植物（從患者身體的另一部分，通常是腿部或胸部取出的健康血管）來繞過冠狀動脈的阻塞部分。這種旁路手術可將血液流向堵塞的動脈周圍，從而改善氧氣和營養物質到心肌。

進行 CABG 手術是為了恢復心臟的充足血流，對於緩解與 CAD 相關的症狀（例如胸痛（心絞痛）和呼吸急促）至關重要。改善血液循環對患者有很大的好處，因為它還可以降低中風的風險並降低呼吸系統併發症的可能性。如果多條動脈被阻塞，外科醫生可能會使用單一或多個移植物來達到最佳效果。

微創CABG手術因其切口少、手術時間短、恢復時間短、術後併發症風險低等優點，越來越受到人們的青睞。在微創手術中使用這些移植物可以有效解決阻塞問題並恢復心臟的健康血液流動，同時降低手術的侵入性並有助於簡化手術過程。

技術創新和改善的患者結果將如何推動冠狀動脈繞道手術設備市場的成長？

冠狀動脈繞道手術的技術進步是這一市場擴張的前沿。機器人輔助手術和內視鏡技術等創新正在改變心血管手術並顯著改善患者的治療效果。這些微創方法可減少手術創傷、加速恢復時間並提高整體手術精確度。先進的機器人醫療影像系統進一步開拓了市場，為外科醫生提供了更高的精確度和靈活性。與傳統方法相比，這些系統提供了手術區域的3D視圖，並使器械移動具有更大的靈活性。此外，術中血管造影術和3D成像等影像技術的創新徹底改變了我們在 CABG 手術期間詳細觀察冠狀動脈和心臟結構的能力。

冠狀動脈疾病盛行率的上升和老年人口的增加也是重要的市場促進因素。冠狀動脈繞道手術對於解決脂肪堆積引起的冠狀動脈阻塞至關重要。冠心病心臟疾病率的不斷上升主要是由於久坐的生活方式、不良的飲食習慣和肥胖率的上升，從而推動了對 CABG 等有效治療方案的需求。醫療保健技術的進步進一步支撐了市場，尤其是在新興國家。對心血管治療用聚合物修復設備製造的大量投資反映了該行業對創新和產品開發的重視。公司正在優先投資新技術和新產品，以滿足心血管領域不斷變化的需求。

機器人輔助微創冠狀動脈繞道手術因其切口少、住院時間短、失血量少、手術精度高等優勢，越來越受到人們的青睞。這一趨勢正在推動對先進 CABG 設備的需求。市場醫療設施的發展也促進了 CABG 設備市場的成長。加強衛生基礎設施和政府舉措（例如衛生與公眾服務部的「百萬心臟」舉措）旨在改善心血管護理並減少心臟病發作和中風。此類公共衛生投資凸顯了對推動冠狀動脈疾病治療方案的承諾，進一步推動了市場成長。

CABG 手術的相關費用將如何阻礙冠狀動脈繞道手術設備市場的成長？

CABG手術的高成本對冠狀動脈繞道手術手術市場的成長構成了挑戰。 CABG 是一項複雜且涉及廣泛的手術，需要大量的資金投入，這可能會限制患者的就診機會，尤其是在醫療保險和財政資源有限的地區。如此高的支出給醫療保健預算帶來了巨大壓力，並可能影響醫療保健系統內的整體醫療支出和護理分配。

此外，介入性心臟病學技術日益激烈的競爭也是一個主要障礙。血管成形術和支架置入術等微創手術正擴大被用作 CABG 的替代方案。這些手術的優點是侵入性較小、恢復時間較短，這使得患者和醫療保健提供者更喜歡這些手術，而不是傳統的 CABG 手術。治療偏好的這種變化可能會減少對 CABG 設備的需求，從而影響市場成長。 CABG手術固有的風險也限制市場的發展。這種手術可能會出現併發症，包括出血、感染和中風，這可能會阻止患者選擇手術並給醫療保健提供者帶來挑戰。這些風險可能導致患者的治療效果更差、醫療成本增加以及普遍不願接受手術，進一步影響市場需求。

此外，熟練的心臟外科醫生在各個地區分佈不均可能會限制接受 CABG 手術的機會。在缺乏合格外科醫生的地區，患者可能會面臨排長隊和治療延誤的問題。這些取得方面的差異可能會對病患照護產生負面影響，並減緩醫療服務不足地區 CABG 設備的普及。

The increasing aging population fuels the growth of coronary artery bypass graft devices. As people age, they become more susceptible to heart diseases, including coronary artery disease (CAD). This demographic shift contributes to a higher incidence of CAD, which in turn boosts the demand for CABG procedures and devices designed to manage and treat these conditions effectively. Thus, the growing geriatric population surge the growth of market size surpassing USD 12 Billion in 2024 to reach a valuation of USD 20.27 Billion by 2032.

Growing awareness of CAD risk factors and the importance of early detection have led to more proactive screening and diagnosis. As public understanding of heart disease improves, there is a greater emphasis on identifying risk factors early and taking preventive measures. This heightened awareness translates into increased demand for diagnostic and treatment options, including CABG devices. The combination of a rising elderly population and proactive health measures is fueli2028-2032ng the growth of the CABG devices market, as healthcare systems and patients seek advanced solutions to address and manage coronary artery disease. Thus, the increasing awareness of CAD enable the market to grow at a CAGR of 7% from 2026 to 2032.

Coronary Artery Bypass Graft Devices Market: Definition/ Overview

Coronary artery bypass graft (CABG) surgery is a crucial medical procedure designed to address coronary artery disease (CAD), a condition characterized by the narrowing or blockage of coronary arteries. This surgical intervention aims to improve blood flow to the heart muscle by creating alternative pathways for blood circulation. During the procedure, a surgeon utilizes grafts-typically healthy blood vessels taken from other parts of the patient's body, such as the leg or chest-to bypass the obstructed sections of the coronary arteries. This bypass redirects blood flow around the clogged arteries, enhancing the delivery of oxygen and nutrients to the heart muscle.

CABG surgery is performed to restore adequate blood flow to the heart, which is essential for alleviating symptoms associated with CAD, such as chest pain (angina) and shortness of breath. By improving blood circulation, the procedure also lowers the risk of stroke and reduces the likelihood of respiratory complications, offering significant benefits to patients. In cases where multiple arteries are blocked, surgeons may use single or multiple grafts to ensure optimal results.

Minimally invasive CABG techniques, which involve fewer incisions and a shorter operational time, are increasingly preferred due to their advantages, including reduced recovery time and lower risk of postoperative complications. The use of these grafts in minimally invasive surgeries helps streamline the procedure, making it less invasive while still effectively addressing the blockage and restoring healthy blood flow to the heart.

How the Innovations and Improving Patient Outcomes Surge the Growth of Coronary Artery Bypass Graft Devices Market?

Technological advancements in CABG procedures are at the forefront of this market expansion. Innovations such as robotic-assisted surgeries and endoscopic techniques have transformed cardiovascular surgery, significantly enhancing patient outcomes. These minimally invasive approaches reduce surgical trauma shorten recovery times and improve overall surgical precision. Further driving the market is the development of advanced robotic medical imaging systems, which provide surgeons with enhanced precision and dexterity. These systems offer a three-dimensional view of the surgical field and allow for greater flexibility in instrument movement compared to traditional methods. Additionally, innovations in imaging technologies, such as intraoperative angiography and three-dimensional imaging, have revolutionized the ability to visualize coronary arteries and cardiac structures in exceptional detail during CABG procedures.

The rise in coronary heart disease prevalence and the growing geriatric population are also crucial market drivers. CABG procedures are essential for addressing coronary artery blockages caused by fatty build-ups. With the increasing incidence of coronary heart disease, largely attributed to sedentary lifestyles, poor dietary habits, and rising obesity rates, there is a higher demand for effective treatment options like CABG. The market is further supported by advancements in healthcare technology, particularly in developing countries. Significant investments in the manufacture of polymer-based restorative devices for cardiovascular treatment reflect the industry's focus on innovation and product development. Companies are prioritizing investment in new technologies and products to meet the evolving needs of the cardiovascular sector.

Minimally invasive CABG surgeries, enabled by robotic assistance, have become increasingly preferred due to their benefits, including fewer incisions, reduced hospitalization periods, less blood loss, and higher surgical accuracy. This trend is pushing the demand for advanced CABG devices. The development of healthcare facilities in emerging markets is also contributing to the growth of the CABG devices market. Enhanced healthcare infrastructure and government initiatives, such as the Million Hearts initiative by the Department of Health & Human Services, aim to improve cardiovascular care and reduce heart attacks and strokes. Such public health investments underscore the commitment to advancing treatment options for coronary diseases, further boosting market growth.

How Does the Cost Associated with the CABG Procedure Impede the Growth of the Coronary Artery Bypass Graft Devices Market?

The high cost associated with CABG procedures challenges the growth of the coronary artery bypass graft devices market. As a complex and intricate surgery, CABG requires a considerable financial investment, which can limit patient access, especially in regions with limited healthcare coverage or financial resources. This high expense places a significant burden on healthcare budgets, potentially affecting the overall affordability and allocation of care within healthcare systems.

Additionally, the growing competition from interventional cardiology techniques presents a considerable restraint. Minimally invasive procedures such as angioplasty and stenting are increasingly being adopted as alternatives to CABG. These procedures offer the advantage of reduced invasiveness and shorter recovery times, which can lead patients and healthcare providers to prefer these options over traditional CABG surgery. This shift in treatment preferences can decrease the demand for CABG devices and impact market growth. The inherent risks associated with CABG surgery also play a role in restraining the market. The procedure carries potential complications, including bleeding, infection, and stroke, which can deter patients from opting for surgery and can also pose challenges for healthcare providers. These risks can lead to negative patient outcomes, increased healthcare costs, and a general reluctance to undertake the procedure, further impacting market demand.

Furthermore, the uneven distribution of skilled cardiac surgeons across different regions can limit the availability of CABG procedures. In areas where there is a shortage of qualified surgeons, patients may face long waiting lists and delays in receiving treatment. This disparity in access can adversely affect patient care and slow down the adoption of CABG devices in underserved regions.

Category-Wise Acumens

How the Minimally Invasive Nature Surge the Growth of Minimally Invasive CABG Devices Segment?

Minimally invasive CABG devices segment shows significant growth in the coronary artery bypass graft devices market. The growing popularity of off-pump coronary artery bypass grafting (CABG) is largely attributed to its minimally invasive nature, which appeals to both patients and surgeons. This approach, performed without the use of a heart-lung machine or cardiopulmonary bypass device, allows the heart to continue functioning normally during the procedure. As a result, patients experience shorter hospital stays and faster recoveries compared to traditional CABG methods. The significant benefits of off-pump CABG, including reduced post-operative complications and a lower risk of bleeding, stroke, and cardiac muscle injury, make it an attractive option for both patients and healthcare providers.

Manufacturers in the CABG devices market can leverage the growing demand for off-pump technology by investing in research and development to enhance their product offerings. The off-pump CABG segment is projected to grow at the fastest rate during the forecast period, driven by continuous innovations and advancements in this technology. These innovations focus on improving safety, efficiency, and overall patient outcomes, thereby expanding the adoption of off-pump procedures in various cardiac treatments.

As the industry moves towards greater adoption of off-pump CABG, manufacturers have a prime opportunity to capitalize on this trend. By expanding their product portfolios and investing in new technologies, they can meet the rising demand for off-pump solutions and strengthen their market position. This segment's growth reflects the broader trend towards minimally invasive surgical techniques, which aim to enhance patient care and surgical outcomes while minimizing recovery times.

How do the Advancements in Cardiovascular Surgery Foster the Growth of the Off-Pump CABG Devices Segment?

Off-pump CABG devices segment shows significant growth in the coronary artery bypass graft devices market. Off-pump coronary artery bypass grafting (CABG) represents a significant advancement in cardiovascular surgery, distinguished by its approach of performing the procedure without the use of a heart-lung machine or cardiopulmonary bypass device. This technique allows the heart to continue its normal function of supplying blood to the body during the surgery, which is a major shift from traditional methods that temporarily halt heart function.

The appeal of off-pump CABG lies in its minimally invasive nature, which offers several advantages. The procedure's reduced invasiveness leads to fewer complications, such as bleeding and stroke, and minimizes the risk of injury to the cardiac muscle. These benefits contribute to enhanced safety and efficiency, making it an attractive option for both patients and surgeons. Additionally, the reduced need for a heart-lung machine means that patients often experience shorter hospital stays and quicker recoveries compared to traditional CABG methods. This rapid recovery is a key factor driving the adoption of off-pump CABG. Manufacturers in the cardiovascular field are increasingly recognizing the potential of off-pump CABG technology. They are investing heavily in research and development to refine this approach and expand their product portfolios. The ongoing innovations by industry players further support the technology's integration into various cardiac procedures, thus propelling the segment's growth. The combination of advanced technology, reduced post-operative complications, and accelerated patient recovery positions off-pump CABG as a leading choice in the evolving landscape of coronary artery bypass surgery.Top of Form

How the Advanced Cardiac Care Infrastructure and Specialized Personnel Surge the Growth of Hospitals Segment?

The hospital segment shows significant growth in the Coronary Artery Bypass Graft Devices Market. Hospitals play a crucial role in the growth of the coronary artery bypass graft (CABG) devices market by investing in advanced cardiac care infrastructure and specialized personnel. Many hospitals are enhancing their cardiac capabilities by equipping their facilities with state-of-the-art cardiac catheterization labs, operating rooms, and intensive care units (ICUs). These upgrades include advanced monitoring and imaging technologies that support precise and effective CABG procedures.

Moreover, hospitals with dedicated cardiac surgery programs benefit from having highly skilled cardiac surgeons, anesthesiologists, and support staff who specialize in performing CABG surgeries. This specialized expertise ensures high-quality care and improves surgical outcomes. Comprehensive postoperative care is also a significant factor, with hospitals providing detailed monitoring in the ICU, effective pain management, and diligent complication management. In addition, cardiac rehabilitation services are offered to help patients recover physically and adjust their lifestyles post-surgery.

The growth in the CABG devices market is further driven by the increasing number of new heart-related cases, which boosts demand for advanced surgical interventions. Additionally, patient preference for healthcare facilities with cutting-edge infrastructure and highly experienced medical professionals contributes to this market expansion. As hospitals continue to enhance their cardiac care capabilities and attract patients seeking the best possible outcomes, the demand for CABG devices and related services is expected to rise accordingly.

Country/Region-wise Acumens

How does the Increasing Prevalence of Cardiovascular Conditions Surge the Growth of the Coronary Artery Bypass Graft Devices Market in North America?

North America is estimated to hold a significant share in the coronary artery bypass graft (CABG) devices market and is poised to maintain its dominant position throughout the forecast period driven by the increase in the global prevalence of cardiovascular conditions, such as coronary artery disease (CAD), strokes, and atrial fibrillation, driven by a rise in lifestyle-related diseases like diabetes and obesity. These health trends are leading to a greater need for CABG procedures, which in turn fuels the demand for surgical grafts and related devices.

The region is also at the forefront of innovation in cardiovascular medicine. Ongoing research efforts are focused on developing new surgical techniques, improving perioperative care, and introducing cutting-edge technologies aimed at optimizing outcomes for CABG surgeries. This commitment to advancement underscores North America's leadership in the field.

Additionally, North America's advanced healthcare infrastructure plays a critical role in sustaining market growth. The region is home to state-of-the-art hospitals and specialized cardiac centers equipped with the latest medical technologies. This high level of infrastructure supports the delivery of exceptional cardiac care and facilitates the effective implementation of advanced CABG procedures. The combination of rising cardiovascular disease prevalence, innovation in medical techniques, and robust healthcare facilities positions North America as a key player in the global CABG devices market.

How the High-Quality Healthcare Infrastructure and Sophisticated Cardiac Interventions Enable the Growth of Coronary Artery Bypass Graft Devices Market in Asia Pacific?

Asia Pacific is anticipated to witness the fastest growth in the coronary artery bypass graft devices market during the forecast period. The rise in disposable income, which allows patients to afford advanced cardiac treatments, including CABG procedures. As more individuals have the financial means to access high-quality healthcare, the demand for sophisticated cardiac interventions continues to grow. Government initiatives also play a crucial role in market expansion. Many governments are investing in healthcare development and promoting cardiovascular health through various programs and policies. These initiatives support the advancement of cardiac care and encourage the adoption of CABG procedures.

Increasing awareness about heart diseases and the importance of early treatment has led to more proactive approaches in diagnosing and managing cardiovascular conditions. This heightened awareness is contributing to early diagnosis and intervention, which drives demand for CABG surgeries and related devices. Medical tourism is another emerging trend contributing to market growth. Some countries have become popular destinations for CABG procedures due to their advanced healthcare facilities and competitive pricing. This trend attracts patients from around the world, further boosting demand for CABG devices.

Additionally, there is a growing adoption of minimally invasive CABG procedures, which offer benefits such as shorter recovery times and reduced post-operative complications. The focus on cost-effective treatment options is also increasing, as both patients and healthcare systems seek to balance quality care with financial considerations. Also, the continuous development of innovative CABG devices is enhancing the effectiveness and safety of these procedures. Advances in technology are leading to the creation of new devices that improve surgical outcomes and patient experiences, driving further growth in the market.

Competitive Landscape

The coronary artery bypass graft (CABG) devices market is characterized by a mix of established medical device companies and specialized players. While the overall market is relatively concentrated, there is ongoing competition based on factors such as product innovation, technological advancements, and geographical reach.

The organizations focus on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the Coronary Artery Bypass Graft Devices Market include:

Terumo Cardiovascular Systems Corporation, Edwards Lifesciences Corporation, Boston Scientific Corporation, Medtronic, Abbott, Teleflex Incorporated, AtriCure, Inc.

Latest Developments:

In August 2022, Medtronic plc announced the acquisition of Affera, Inc. This acquisition increased the company's cardiac ablation portfolio by adding its first cardiac mapping and navigation platform. The platform includes a novel, completely integrated diagnostic, focal pulsed field, and radiofrequency ablation solution.

In August 2022, the Grand Pharmaceutical Group of China invested EUR 15 million in Xeltis, a well-known medical device company with clinical-stage headquarters in the Netherlands. Grand Pharmaceutical has developed a polymer-based cardiovascular therapy device. CABG surgery uses heart valves and blood arteries with tiny diameters as restoration devices.

In January 2022, Humacyte, Inc. released data from the first preclinical investigation of the use of Humacyte's small-diameter (3.5mm) Human Acellular Vessel (HAV) in CABG at Advanced Therapies Week.